Source:http://linkedlifedata.com/resource/pubmed/id/15232171
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2004-7-2
|
pubmed:abstractText |
Group A streptococcal C5a peptidase (SCPA) is a major virulence surface factor. Its highly conserved nature among all tested serotypes of group A streptococci (GAS) as well as animal protection studies make SCPA a prime vaccine candidate. The present study was undertaken to explore the human immunogenicity to SCPA using an indirect enzyme-linked immunosorbent assay.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0971-5916
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
119 Suppl
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
95-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15232171-Adhesins, Bacterial,
pubmed-meshheading:15232171-Child,
pubmed-meshheading:15232171-Child, Preschool,
pubmed-meshheading:15232171-Endopeptidases,
pubmed-meshheading:15232171-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:15232171-Humans,
pubmed-meshheading:15232171-Streptococcal Infections,
pubmed-meshheading:15232171-Streptococcus pyogenes
|
pubmed:year |
2004
|
pubmed:articleTitle |
Human immunogenicity studies on group A streptococcal C5a peptidase (SCPA) as a potential vaccine against group A streptococcal infections.
|
pubmed:affiliation |
Department of Pediatrics, World Health Organization Collaborating Center for Reference & Research on Streptococci, University of Minnesota Medical School, Minneapolis, MN 55455, USA. shetx002@umn.edu
|
pubmed:publicationType |
Journal Article
|